Patents Assigned to Astacarotene AB
-
Patent number: 6923967Abstract: Use of a at least one type of xanthophylls for the preparation of a medicament for prophylactic and/or therapeutic treatment of dyspepsia, is disclosed. The xanthophyll is preferably astaxanthin, e.g. astaxanthin is in a form esterified with fatty acids, such as in algal meal prepared from a culture of the alga Haematococcus sp. The medicament may further comprise carbohydrate structures and/or (a) different antioxidant(s). Further, a method of prophylactic and/or therapeutic treatment of dyspepsia in an individual, is described. The method comprises administration to said individual of an dyspepsia-alleviating amount of a medicament comprising at least one type of xanthophylls.Type: GrantFiled: October 8, 1999Date of Patent: August 2, 2005Assignee: Astacarotene ABInventor: Ake Lignell
-
Patent number: 6475547Abstract: A method of producing immunoglobulin-rich milk, including colostrum, in mammalian mothers, is described. The method includes administration of an effective daily dosage of a preparation containing at least one type of xanthophylls, such as astaxanthin, to said mothers, e.g. cows. Immunoglobulin-rich milk, including colostrum, produced according to the method and immunoglobulin concentrates derived from such milk, including colostrum, are also disclosed. These products may be used as nutrient for mammals, and as raw material for diagnostics, human and veterinary medicines, dermatologic preparations and cosmetics industry.Type: GrantFiled: July 25, 2000Date of Patent: November 5, 2002Assignee: AstaCarotene ABInventors: Ake Lignell, Johan Inborr
-
Patent number: 6410602Abstract: A method of increasing the volume, the total sperm count and the reproductive performance of semen from human and animal males, is described. The method comprises administration of an effective dosage of a human or veterinary preparation containing at least one type of xanthoplylls, such as astaxanthin, to said males. Preferably, the astaxanthin exists in a form esterified with fatty acids, e.g. in the form of algal meal produced by culturing of the alga Haematococcus sp. Further, the use of at least one type of xanthophylls, such as astaxanthin, for the preparation of a human or veterinary preparation for increasing the volume, the total sperm count and the reproductive performance of semen from human and animal males, is disclosed.Type: GrantFiled: June 6, 2000Date of Patent: June 25, 2002Assignee: Astacarotene ABInventors: Ake Lignell, John Inborr, Curt Nicolin
-
Patent number: 6335015Abstract: A method of prophylactic treatment of mastitis in mammalian, including human, mothers, is described. The method comprises administration of a prophylactically effective dosage of a human or veterinary medicament containing at least one type of xanthophylls, such as astaxanthin, to said mothers. Preferably, the astaxanthin exists in a form esterified with fatty acids, e.g. in the form of algae meal produced by culturing of the alga Haematococcus sp. Further, use of at least one type of xanthophylls, such as astaxanthin, for the preparation of a human or veterinary medicament for the prophylactic treatment of mastitis is mammalian, including human, mothers is disclosed.Type: GrantFiled: July 25, 2000Date of Patent: January 1, 2002Assignee: Astacarotene ABInventors: Ake Lignell, Johan Inborr
-
Patent number: 6262316Abstract: An oral preparation for the prophylactic and/or therapeutic treatment of inflammation in the mucous membrane of mammalian gastrointestinal tract (especially the human stomach) caused by Hicobacter sp. (especially H. pylori) infection is described. The preparation comprises a prophylactically and/or therapeutically effective amount of at least one type of xanthophylles. The most preferred xanthophyll is astaxanthin which is soluble in oil, preferably naturally produced astaxanthin which is esterified with fatty acids. The oral preparation may further comprise carbohydrate structures, such as those which derive from the cell wall of the production alga Haematococcus sp. The preparation may also comprise a prophylactically and/or therapeutically effective amount of a water soluble antioxidant, such as ascorbic acid (vitamin C). The oral preparation is presented in a separate unit dose or in mixture with food.Type: GrantFiled: January 21, 2000Date of Patent: July 17, 2001Assignee: Astacarotene ABInventors: Torkel Wadström, Pär Alejung
-
Patent number: 6245818Abstract: Medicament for the prophylactic and/or therpeutic improvement of the duration of mammalian muscle function and/or treatment of mammalian muscle disorders or diseases, e.g. equine Exertional Rhabdomyolysis, comprising at least one type of xanthophylles, e.g. astaxanthin, is described. Further, the use of xanthophylles in the preparation of such medicaments, and a method of prophylactic and/or therapeutic improvement of the duration of mammalian muscle function and/or treatment of mammalian muscle disorders or diseases, are disclosed.Type: GrantFiled: February 29, 2000Date of Patent: June 12, 2001Assignee: Astacarotene ABInventor: Ake Lignell
-
Patent number: 6054491Abstract: A method of increasing the production of/in breeding and production mammals by administering an agent which consists of at least one type of xanthophylles, preferably astaxanthin, in the feed to animals, is disclosed.Type: GrantFiled: September 25, 1998Date of Patent: April 25, 2000Assignee: Astacarotene ABInventors: .ANG.ke Lignell, Johan Inborr
-
Patent number: 5744502Abstract: The present invention discloses a method of increasing the production of/in breeding and production animals in the poultry industry by administering an agent which consists of at least one type of xanthophylles, preferably astaxanthin, in the feed to animals.Type: GrantFiled: April 30, 1997Date of Patent: April 28, 1998Assignee: Astacarotene ABInventors: .ANG.ke Lignell, Curt Nicolin, Lars-Hak.ang.n Larsson, Johan Inborr